- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03106090
Studying Survivorship Care Plans in Head and Neck Cancer
14 januari 2020 bijgewerkt door: Duke University
Comparison of Enhanced Survivorship Care Plans in a Head and Neck Cancer Clinic to Standard of Care
The study will focus on survivorship care for head and neck cancer patients cared for within Duke Cancer Center clinics.
Standardized survivorship care plans (sSCP) are being implemented based on the American Society for Clinical Oncology's criteria.
These documents provide a summary of treatment received, and list side effects and follow-up information after cancer treatment.
Taking advantage of this transition, the investigator will study three groups of patients: (a) early survivors treated before the sSCP was implemented, (b) early survivors treated after the sSCP was implemented, and (c) current patients who will receive an individualized enhanced SCP (eSCP), which will include additional information tailored to patient preferences.
The investigators hypothesize that patients receiving enhanced survivorship care plans will increase their knowledge regarding their health care plan and wellness trajectory; increase their ability to identify the symptoms they most likely can expect as a result of their cancer treatment; and be more likely to engage in conversations with their PCP about healthy behaviors and screening guidelines.
Studie Overzicht
Studietype
Ingrijpend
Inschrijving (Werkelijk)
6
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studie Locaties
-
-
North Carolina
-
Durham, North Carolina, Verenigde Staten, 27710
- Duke Health, Duke Cancer Center
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
18 jaar en ouder (Volwassen, Oudere volwassene)
Accepteert gezonde vrijwilligers
Nee
Geslachten die in aanmerking komen voor studie
Allemaal
Beschrijving
Inclusion Criteria:
- Completed treatment for a head or neck cancer at Duke Cancer Center within 4 months of consent OR
- Will complete treatment for a head and neck cancer at Duke Cancer Center within 3 weeks of consent AND
- Able to read and understand English
- Capable of giving informed consent
- Are at least age 18.
Exclusion Criteria:
- incompetent for interview (documented diagnosis of active psychosis or dementia) or unable to provide informed consent as assessed by the interviewer; or too sick to participate, as judged by a member of the research team
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Niet-gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Geen tussenkomst: No SCP Control
Patients returning for early follow-up who did not receive SCP.
|
|
Geen tussenkomst: SOC SCP Control
Patients returning for early follow-up who received a standard of care SCP.
|
|
Experimenteel: eSCP Intervention
Patients currently receiving treatment who will be enrolled to receive an "enhanced" SCP (eSCP) with additional information beyond ASCO guidelines tailored to patient concerns and preferences.
|
The eSCP includes a treatment summary section, a section detailing follow-up and test recommendations, a section on anticipated and potential side effects, as well as additional information specific to their experience/concerns.
They will receive a patient education notebook outlining symptoms and their management that is tailored to those that the subject may be likely to experience during their survivorship care trajectory.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Head and Neck Cancer Survivor Knowledge
Tijdsspanne: 5 minutes to complete 3 months after treatment end
|
Assesses survivor knowledge of potential cancer or treatment-related symptoms and knowledge of healthy behaviors through the use of the Head and Neck Cancer Survivor Knowledge Scale
|
5 minutes to complete 3 months after treatment end
|
Change in Head and Neck Cancer Survivor Knowledge
Tijdsspanne: 5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Assesses survivor knowledge of potential cancer or treatment-related symptoms and knowledge of healthy behaviors through the use of the Head and Neck Cancer Survivor Knowledge Scale in intervention group
|
5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Distress in head and neck cancer survivors
Tijdsspanne: 5 minutes to complete 3 months after treatment end
|
Assesses risk of distress defined within post-traumatic stress after treatment through the use of the PTSD Checklist
|
5 minutes to complete 3 months after treatment end
|
Distress in head and neck cancer survivors
Tijdsspanne: 5 minutes to complete 3 months after treatment end
|
Assesses distress through the use of the NCCN Distress Thermometer
|
5 minutes to complete 3 months after treatment end
|
Change in distress for head and neck cancer survivors
Tijdsspanne: 5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Assesses risk of distress defined within post-traumatic stress after treatment through the use of the PTSD Checklist in the intervention group
|
5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Change in distress for head and neck cancer survivors
Tijdsspanne: 5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Assesses distress through the use of the NCCN Distress Thermometer in the intervention group
|
5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Uncertainty in head and neck cancer survivors
Tijdsspanne: 5 minutes to complete 3 months after treatment end
|
Assesses uncertainty related to presence of symptoms after cancer treatment through the use of the Mishel Uncertainty in Illness Scale -Survivor/Caregiver form
|
5 minutes to complete 3 months after treatment end
|
Change in uncertainty in head and neck cancer survivors
Tijdsspanne: 5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Assesses uncertainty related to presence of symptoms after cancer treatment through the use of the Mishel Uncertainty in Illness Scale -Survivor/Caregiver form in the intervention group
|
5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Quality of life in head and neck cancer survivors
Tijdsspanne: 5 minutes to complete 3 months after treatment end
|
Assesses quality of life in head and neck cancer patients EORTC Quality of Life Questionnaire Head & Neck (QLQ H&N35)
|
5 minutes to complete 3 months after treatment end
|
Change in quality of life in head and neck cancer survivors
Tijdsspanne: 5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Assesses quality of life in head and neck cancer patients EORTC Quality of Life Questionnaire Head & Neck (QLQ H&N35) in the intervention group
|
5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Self-efficacy in head and neck cancer survivors
Tijdsspanne: 5 minutes to complete 3 months after treatment end
|
Assesses self-efficacy in cancer patients through the use of the Self-Efficacy Scale
|
5 minutes to complete 3 months after treatment end
|
Change in self-efficacy in head and neck cancer survivors
Tijdsspanne: 5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Assesses self-efficacy in cancer patients through the use of the Self-Efficacy Scale
|
5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Information processing in head and neck cancer survivors
Tijdsspanne: 5 minutes to complete 3 months after treatment end
|
Assesses information processing in cancer patients through the use of the EORTC QLQ Information Module (QLQ INFO25)
|
5 minutes to complete 3 months after treatment end
|
Change in information processing in head and neck cancer survivors
Tijdsspanne: 5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Assesses information processing through the use of the EORTC QLQ Information Module (QLQ INFO25)
|
5 minutes to complete; measured pre-intervention and 3 months after intervention
|
Survivorship care plan perceptions in head and neck cancer survivors
Tijdsspanne: 5 minutes to complete 3 months after treatment end
|
Using open ended questions during a qualitative interview, survivors will provide their perception of how survivorship care plans were useful or not in their care
|
5 minutes to complete 3 months after treatment end
|
Survivorship needs after treatment completion -- primary care provider documentation
Tijdsspanne: 10 minutes to complete documentation review of 6 months of PCP records
|
Using a documentation checklist developed by the study team, discussions on survivorship needs when returning to clinic will be assessed with a focus on symptom management or incorporation of healthy behaviors to reduce cancer recurrence
|
10 minutes to complete documentation review of 6 months of PCP records
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Sponsor
Onderzoekers
- Hoofdonderzoeker: Deborah H Allen, PhD, RN, Duke Health
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start (Werkelijk)
19 april 2017
Primaire voltooiing (Werkelijk)
2 januari 2020
Studie voltooiing (Werkelijk)
2 januari 2020
Studieregistratiedata
Eerst ingediend
29 maart 2017
Eerst ingediend dat voldeed aan de QC-criteria
4 april 2017
Eerst geplaatst (Werkelijk)
10 april 2017
Updates van studierecords
Laatste update geplaatst (Werkelijk)
18 januari 2020
Laatste update ingediend die voldeed aan QC-criteria
14 januari 2020
Laatst geverifieerd
1 januari 2020
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- Pro00079937
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
NEE
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Nee
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Nee
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op educational materials
-
Université de MontréalOnbekendChirurgische opleiding | Geavanceerde hechtvaardigheden
-
University of Sao Paulo General HospitalOnbekendArtrose van de knieBrazilië